With 57% of German tax advisors over 50 and approaching retirement, Berlin-based AnyTax has secured €1 million in pre-Seed funding to build embedded tax solutions for financial platforms. The startup aims to address Germany’s looming tax advisory crisis through API-first infrastructure.
The tokenization infrastructure leader Securitize is taking the public route through a SPAC merger with Cantor Fitzgerald’s affiliate. This move validates the $4 billion tokenized asset market and signals institutional blockchain adoption accelerating.
As Gen Z reports record-low workplace engagement and influence, employee ownership models are emerging as a surprising solution. Companies with ESOPs show 50% higher employee tenure and dramatically improved satisfaction among younger workers.
Standard Economics, founded by former SpaceX and X employees, has raised $9 million to tackle cross-border payments for the unbanked. Their Uno app launches first in Mexico using stablecoins to eliminate fees and delays. The startup aims to create a global financial access platform.
Voyager Technologies’ acquisition of propulsion specialist ExoTerra Resources signals a major consolidation in the space defense sector. The deal positions Voyager to address critical national security gaps in space maneuverability.
Shopify’s 21% surge raises valuation alarms. While operations remain strong, stretched multiples and market saturation create headwinds. Here’s what investors should consider.
Sam Altman is building a brain-computer interface startup called Merge Labs that will take a dramatically different approach from Neuralink. The OpenAI CEO has recruited Caltech biomolecular engineer Mikhail Shapiro, whose work focuses on using ultrasound and gene therapy to read brain activity without surgery. The hiring signals Altman’s preference for non-invasive neural interfaces over approaches that require implanting electrodes in the brain.
Sam Altman is quietly assembling the pieces for his next major venture, and it’s shaping up to be a direct challenge to Neuralink’s vision of how humans should interface with machines. According to sources familiar with the matter, Altman has recruited Caltech professor Mikhail Shapiro—an award-winning biomolecular engineer—to join Merge Labs, a brain-computer interface startup expected to launch publicly in the coming weeks.
Electric vehicle maker Rivian will pay $250 million to resolve a class-action lawsuit filed by shareholders after sudden price increases on its R1 vehicles. The settlement comes as the company prepares for its crucial R2 SUV launch amid declining R1 sales and recent layoffs.
Electric vehicle manufacturer Rivian has reportedly agreed to pay $250 million to settle a class-action shareholder lawsuit stemming from controversial price increases on its R1 vehicles in 2022, according to court documents and company statements. The lawsuit alleged that Rivian included misleading information about production costs in its IPO documentation prior to going public in 2021.
Oxford-based quantum technology startup QFX has raised €2.2 million in seed funding to advance its modular hardware platform. The investment round was reportedly led by Y Combinator co-founder Paul Graham, positioning the University of Oxford spin-out within Europe’s growing quantum ecosystem.
Oxford-based quantum startup QFX has secured €2.2 million in seed funding to expand its modular hardware platform for quantum technologies, according to recent reports. Sources indicate the investment round was led by Silicon Valley investor and Y Combinator co-founder Paul Graham, signaling strong confidence in the UK quantum sector.
Longevity researchers are urging the rapidly expanding anti-aging industry to shift focus from extending lifespan to improving healthspan. Experts emphasize that adding healthy years provides more value than merely prolonging life, with exercise emerging as today’s most accessible fountain of youth.
The booming longevity industry is facing a crucial recalibration as leading researchers advocate for a fundamental shift in focus from extending lifespan to improving healthspan, according to discussions at the recent Inc. 5000 Conference in Phoenix. Sources indicate that despite massive commercial investment in anti-aging technologies, the core philosophy among serious researchers centers on expanding years of healthy life rather than simply prolonging existence.
